In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa

BACKGROUND: Multidrug-resistant Pseudomonas aeruginosa has emerged as one of the most important healthcare-associated pathogens. Colistin is regarded as the last-resort antibiotic for multidrug-resistant Gram-negative bacteria, but is associated with high rates of acute kidney injury. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yi-Fan, Liu, Chang-Pan, Wang, Nai-Yu, Shih, Shou-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995756/
https://www.ncbi.nlm.nih.gov/pubmed/27553962
http://dx.doi.org/10.1186/s12879-016-1785-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995756/
https://www.ncbi.nlm.nih.gov/pubmed/27553962
http://dx.doi.org/10.1186/s12879-016-1785-7

Ejemplares similares